Table: OncoTherapy Science -2020/21 parent results
May 7 (Reuters)-
OncoTherapy Science Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2021 Mar 31, 2020 Mar 31, 2022 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 111 mln 114 mln
(-2.7 pct) (-44.3 pct)
Operating loss 1.37 loss 1.82
Recurring loss 1.34 loss 1.79
Net loss 1.55 loss 1.98
EPS loss 8.77 yen loss 12.13 yen
Ann Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - OncoTherapy Science Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T